Umbilical Cord Mesenchymal Stem Cells and Wnt Pathway Modulation: A Novel Therapy for Liver Cirrhosis and Steatosis
Tissue Engineering and Regenerative Medicine · 2026-04 · 23 (3) · 439-461
DOI: 10.1007/s13770-025-00780-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering and Regenerative Medicine, online erschienen am 17.01.2026. Verfasst von Yanxuan Wen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, 410013, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Wnt Signaling Pathway, Umbilical Cord, Liver Cirrhosis. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: The Wnt signalling pathway, one of the key classical stem cell pathways, plays an important role in helping the liver regenerate after injury. Stem cells can influence changes in adult cell behaviour by either activating or inhibiting this pathway. When liver damage is severe, the organ's ability to regenerate may be compromised, sometimes leading to structural changes. Umbilical cord-derived mesenchymal stem cells have shown promise in improving the liver microenvironment more effectively through the classical Wnt pathway. METHODS: Studies were conducted on both reviews and original experiments. This paper used a repeated-measures design, and statistical analysis was performed using a two-factor, two-level repeated-measures model to analyze the experimental results. The measurements taken before and after the intervention were compared, and interactions were examined. C57/6 BAL mice were randomly divided into two to three groups, with in vivo Choline-methionine deficiency C57 black mouse animal disease models, and hepG2 replace complex intake primary liver cell problem to mimic in vitro cell models simulated. One sample from each group was randomly selected for model validation, and stem cell injection experiments were conducted after validation. The experiments were carried out in a wholly randomized manner to explore the phenotype and intrinsic mechanisms of liver cirrhosis and steatosis. RESULTS: In cirrhosis, inflammatory fibrosis, endoplasmic reticulum stress, and mitochondrial damage are key virulent factors in the primary stage. After treating mice for a month and a half, the AST content in the peripheral blood plasma of animals and the expression of ALT increased. The interventional treatment of umbilical cord mesenchymal cell infusion (three times a month at doses of 105, 4 × 105, or 106) has further contributed to understanding the underlying mechanisms. The Wnt pathway plays a significant role in organ and tissue reversing function (p < 0.05). CONCLUSION: Umbilical cord mesenchymal stem cells were used to treat cirrhosis, ranging from end-stage to early stages, in methionine-deficient rats by modulating the Wnt pathway. It can inhibit the progression of steatosis-related inflammation and fibrosis, further depresses cirrhosis in mice and humans, and underscores the significance of umbilical stem cells in public health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, 410013, China.
- CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Center for Cell Linea…
- Department of Applied Biology, College of Science and Technology, University of Rwanda, Avenue de l'armée, P.O. Box: 3900, Kigali, Rwanda.
- Rwanda Food and Drugs Authority, Nyarutarama Plaza, KG 9 Avenue, P.O. Box 1948, Kigali, Rwanda.
- Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ, 85259, USA.
- Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, 410013, China. dsh870102520@163.com.
Zitieren
APA
Wen, Y., Amjad, N., Mukamab, O., Amissah, O. B., Xie, W., Zhou, P., Song, A., Wang, L., Li, J., Huang, R., Deng, S., & Li, Z. (2026). Umbilical Cord Mesenchymal Stem Cells and Wnt Pathway Modulation: A Novel Therapy for Liver Cirrhosis and Steatosis. Tissue Engineering and Regenerative Medicine, 23(3), 439-461. https://doi.org/10.1007/s13770-025-00780-3
Vancouver
Wen Y, Amjad N, Mukamab O, Amissah OB, Xie W, Zhou P, et al. Umbilical Cord Mesenchymal Stem Cells and Wnt Pathway Modulation: A Novel Therapy for Liver Cirrhosis and Steatosis. Tissue Engineering and Regenerative Medicine. 2026;23(3):439-461. doi:10.1007/s13770-025-00780-3
BibTeX
@article{Wen2026,
author = {Wen, Yanxuan and Amjad, Nouman and Mukamab, Omar and Amissah, Obed Boadi and Xie, Wei and Zhou, Peng and Song, Aishi and Wang, Lan and Li, Jiaxing and Huang, Rongqi and Deng, Sihao and Li, Zhiyuan},
title = {Umbilical Cord Mesenchymal Stem Cells and Wnt Pathway Modulation: A Novel Therapy for Liver Cirrhosis and Steatosis},
journal = {Tissue Engineering and Regenerative Medicine},
year = {2026},
volume = {23},
number = {3},
pages = {439--461},
doi = {10.1007/s13770-025-00780-3}
}
EUVIMED